期刊文献+

奈必洛尔对非对称性二甲基精氨酸诱导损伤人脐静脉内皮细胞的保护作用研究

Protective Effect of Nebivolol on the Asymmetrical Dimethylarginine-induced Injury of Human Umbilical Vein Endothelial Cells
下载PDF
导出
摘要 目的观察奈必洛尔对非对称性二甲基精氨酸(ADMA)诱导损伤人脐静脉内皮细胞(HUVECs)的保护作用。方法用ADMA16μmol/L培养HUVECs 24 h,不加或加入阿替洛尔20μmol/L、奈比洛尔(5μmol/L、10μmol/L、20μmol/L)预处理1 h。0.25%胰酶消化细胞,获取细胞悬液,离心收集细胞上清液,检测一氧化氮(NO)水平、一氧化氮合酶(NOS)活性。提取HUVECs总RNA,用RT-PCR分析内皮型一氧化氮合酶(eNOS)mRNA表达。结果 ADMA16μmol/L刺激HUVECs 24 h后,上清液NO含量和NOS活性降低,eNOS mRNA表达下调。奈比洛尔可剂量依赖性抑制ADMA所致的上述损伤。阿替洛尔对ADMA诱导的损伤无显著改善。结论奈必洛尔可保护ADMA诱导损伤HUVECs。 Objective To investigate the protective effect of nebivolol on asymmetrical dimethylarginine (ADMA) induced injury of hu -man umbilical vein endothelial cells (HUVECs).Methods HUVECs were cultured with ADMA 16μmol/L for 24 hours in the absence orpresence of nebivolol (5μmol/L,10μmol/L or 20μmol/L) or atenolol (20μmol/L) for 1 hour.The supernaent in the conditioned mediumwas collected by centrifugation for determination of nitric oxide (NO) and nitric oxide synthase (NOS) activities.The expression of en -dothelial nitric oxide synthase (eNOS) mRNA was measured by real time polymerase chain reaction (RT PCR).Results After theculture of HUVECs with ADMA 16μmol/L for 24 hours,the NO content and NOS activity in the supernatant decreased,and the expres -sion of eNOS mRNA was down regulated.Pretreatment with nebivolol concentration dependently attenuated the ADMA inducedinjury.Atenolol had no influence on the effects induced by ADMA.Conclusion Nebivolol protects the ADMA induced injury of HU -VECs
作者 殷莎 魏泽卉 张飞 王燕 Yin Sha;Wei Zehui;Zhang Fei;Wang Yan(Shanxi Medical University,Taiyuan 030001,Shanxi,China)
机构地区 山西医科大学
出处 《中西医结合心脑血管病杂志》 2018年第17期2491-2494,共4页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
基金 国家自然青年科学基金资助项目(No.81503075)
关键词 奈必洛尔 非对称性二甲基精氨酸 一氧化氮 内皮型一氧化氮合酶 阿替洛尔 nebivolol asymmetric dimethylarginine nitric oxide endothelial nitric oxide synthase atenolol
  • 相关文献

参考文献4

二级参考文献76

  • 1Intengan ID,Sehiffein EL.Disparate effects of carvedilol versus metoprolol treatment of stroke-prone spontaneously hypertensive rats on endothelial function of resistance arteries[J].J Cardiovase Pharmacol,2000,35(5):763-768.
  • 2Van B,Fici F,Mascagni F.Efficacy and tolerability of nebivolol compared with other antihypertensive drugs:A meta-analysis[J].Am J Cardiovasc Drugs,2008,8(1):35-44.
  • 3Cockcroft J.A review of the safety and efficacy of nebivolol in the mildly hypertensive patient[J].Vasc Health Risk Manag,2007,3(6):909-917.
  • 4Mason RP,Kubant R,Jacob RF,et al.Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals:Role of antioxidant activity[J].J Cardiovasc Pharmacol,2006,48(1):862-869.
  • 5Ladage D,Brixius K,Hoyer H,et al.Mechanisms underlying nebivolol-induced endothelial nitric oxide synthase activation in human umbilical vein endothelial cells[J].Clin Exp Pharmacol Physiol,2006,33(8):720-724.
  • 6Estela G,Felipe V,Noelia A,et al.Long-Term treatment with nebivolol improves arterial reactivity and reduces ventricular hypertrophy in spontaneously hypertensive Rats[J].J Cardiovasc Pharmacol,2003,42:348-355.
  • 7Boger RH, Bode-Boger SM. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway and cardiovascular disease. Semin Thromb Hemost, 2000, 26 (5): 539-545.
  • 8Andrew JM. Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases. Nitric Oxide: Biology and Chemistry, 2002, 6 (2): 101-124.
  • 9Verma S, Anderson TJ. Fundamental of endothelial function for the clinical cardiologist. Circulation, 2002, 105 (5): 546-549.
  • 10Vallance P, Leiper J. Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol, 2004, 24 (6): 1 023-030.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部